Imaging Market at a Glance

As of 2022, the global MRI installed base was estimated at ~50 000 MRI systems, supporting >95 million MRI scans per year worldwide. This explains why productivity, uptime, and workflow automation are now treated as core product requirements.

From a vendor lens, Siemens Healthineers sizes the global imaging addressable market at more than EUR 31 billion in FY2025. This reinforces that the category is already a large, replacement-driven market where differentiation is increasingly delivered through software, services, and productivity guarantees.

Further, a 2025 analysis reported 950 AI/ML devices authorized by the FDA, with 723 in radiology, quantifying how radiology remains the primary commercialization beachhead for clinical AI.

In Canada (FY2022-2023), publicly funded CT utilization reached ~6.4 million examinations, equal to 160.2 exams per 1000 people, and was reported as +9% since 2015. This demand trajectory keeps pressure on scanner availability, radiographer staffing, and reporting throughput.

Enterprise Imaging Expands as Outpatient Platforms Grow

Peer-reviewed evidence continues to support time-to-scan as a primary AI value lever. One MRI-focused review highlighted an accelerated lumbar MRI protocol where a deep learning reconstruction approach reduced average acquisition time by 32.3% versus standard protocols while maintaining image quality.

Siemens Healthineers announced a GBP 250 million (USD 314 million) Oxfordshire magnet facility to support 1300+ jobs, positioned as additional capacity to meet rising MRI demand and explicitly described as featuring high-end manufacturing automation technology.

This illustrates why vendors are prioritizing reconstruction, protocolling, and automation rather than only detection algorithms.

The global diagnostic imaging market size is anticipated to reach around USD 76.69 billion by 2034, expanding at a CAGR of 4.84% from 2025 to 2034.

The imaging industry is supported by 224 700+ total companies, including approximately 38 300 startups actively developing diagnostic, clinical, and digital imaging solutions. While the sector records a yearly growth rate of 1.26%, this sector signals short-term consolidation rather than structural decline.

 

 

From a workforce perspective, the imaging ecosystem employs 11.1 million professionals globally and added 3700+ new employees in the last year. It indicates continued demand for technical, clinical, and data-driven expertise despite moderated company growth.

Geographically, industry activity concentrates in the US, India, the UK, France, and Germany, supported by strong healthcare infrastructure and research investment.

 

 

Where AI Reconstruction Cuts MRI Acquisition Time

Yellowbird Diagnostics develops Biomedical Imaging Agents

Yellowbird Diagnostics, a Canadian startup, creates plug-and-play imaging dyes for medical imaging procedures. It designs contrast agents that integrate directly into existing positron emission tomography (PET) and magnetic resonance imaging (MRI) workflows. These agents visualize biological processes that remain undetected with conventional imaging.

Through NeuCaVis, a PET radiotracer, the startup deploys imaging technology that visualizes inflammation as a metabolic disease driver while reducing complexity in patient preparation.

FilTrak is a metal-free MRI dye platform that offers functional kidney mapping for patients excluded from standard MRI scans.

In parallel, Aurogami employs nanomaterial-based dye technology to identify cardiac and vascular inflammation within interventional cardiology workflows.

Living Optics manufactures Hyperspectral Imaging Cameras

UK-based startup Living Optics designs hyperspectral imaging cameras that capture spatial and spectral data simultaneously at video frame rates.

The camera integrates a visible-near infrared (VIS-NIR) spectral imaging sensor with onboard edge compute to process high-dimensional spectral information in real time within a single portable system.

Through its camera and development kit, the startup employs embedded graphics processing unit (GPU) computing to support live image processing and spectral analysis. It provides a software development kit (SDK) that enables smooth alignment with established computer vision frameworks.

The camera and software stack offer developer-ready tools, application programming interfaces (APIs), and field accessories that support rapid deployment across laboratory, industrial, and field environments.

AIATELLA deploys Automated Imaging Measurement (AIM) Solutions

AIATELLA, a Finnish startup, creates automated imaging measurement technology for cardiovascular analysis. It applies AI to radiology workflows by converting manual cardiovascular measurements into standardized, automated analyses across multiple imaging modalities.

Through the Aorta AIM solution, the startup processes current and historical images to quantify and track aortic pathologies over time. It compiles results into structured reports that operate directly within picture archiving and communication systems (PACS).

The Aorta AIM reduces manual workload, supports consistent analysis across growing imaging volumes, and preserves diagnostic accuracy.

OWLO designs 3D Non-invasive and Real-time Microscope

OWLO, a French startup, designs three-dimensional non-invasive microscopy technology.

The startup shifts complexity from microscopy hardware to software processing by combining an intelligent illumination module with computational algorithms to capture volumetric information using standard microscopes.

Through its software platform, the startup applies wave physics-based algorithms to reconstruct and visualize three-dimensional images in real time at significant tissue depths.

This microscopy system delivers label-free, high-resolution imaging suitable for both in vitro and in vivo applications, including embryo assessment, drug discovery, and ophthalmic diagnostics.

SpeXICAM specializes in X-ray imaging

SpeXICAM, a Belgian startup, provides hyperspectral X-ray imaging technology. The imaging technology combines software, custom readout hardware, and a patented sensor acquisition approach to capture detailed spectral and spatial X-ray data across extended imaging areas.

Through its SpeXIDAQ software suite, the startup processes and visualizes hyperspectral sensor output using a modular, network-based architecture that supports customization. integration, and future sensor requirements.

In parallel, its WiggleCam technique aligns multi-tile sensor arrays at the acquisition level to remove gaps and increase spatial resolution while maintaining sharp image quality.

Gain Comprehensive Insights into Imaging Trends

Discover the emerging trends in the imaging market along with their firmographic details:

 

Precision Medicine

This domain aligns diagnostic imaging with patient-specific biological, genetic, and clinical data. Imaging platforms integrate radiomics, genomics, and AI models to support individualized diagnosis, treatment planning, and therapy monitoring.

This segment strengthens imaging’s role in oncology, cardiology, and neurology by enabling earlier detection and more targeted interventions.

From a firmographic perspective, 19 800 companies actively operate in imaging-driven precision medicine and employ approximately 1.1 million professionals worldwide.

The addition of 650+ new employees in the last year reflects steady talent demand. Also, the domain consists of an annual growth rate of 5.82%, which indicates stable expansion driven by clinical adoption, regulatory approvals, and growing demand for personalized diagnostics.

Biomarkers

Biomarkers are vital for imaging innovation by linking visual data with biological indicators such as proteins, metabolites, and genetic signatures. Imaging biomarkers support disease stratification, therapy response assessment, and longitudinal patient monitoring. In clinical practice, this segment improves diagnostic accuracy and reduces reliance on invasive procedures.

The biomarker segment within the imaging market includes 6400 companies, supported by a workforce of 270 700 employees. Over the past year, the sector added 280+ new employees and reflects targeted hiring in imaging analytics, molecular imaging, and clinical validation roles.

With a growth rate of 7.30%, biomarker-based imaging outpaces several traditional imaging subsegments, driven by translational research, pharmaceutical partnerships, and growing use in clinical trials.

Edge Computing

This enables real-time data processing at scanners, imaging devices, and hospital networks. This approach reduces latency, limits cloud reliance, and accelerates clinical decision-making in emergency imaging, point-of-care diagnostics, and remote care settings. At the same time, edge-based imaging strengthens data security and regulatory compliance by minimizing data transfers.

This segment consists of 142 300 companies active in edge-enabled imaging and digital infrastructure. It employs 1.05 million professionals and added 2800 new employees in the last year. An annual growth rate of 5.26% positions edge computing as the vital imaging trend and a core enabler of responsive imaging operations.

Capital & Deals: USD 2.3B Enterprise Imaging M&A

OEM investment is increasingly framed around digitization and customer experience infrastructure. Siemens Healthineers’ USD 150 million investment in new and expanded US facilities includes a 60 000 square feet Experience Center and supply depots intended to raise parts availability by nearly a third.

Large-scale consolidation remains active in imaging-adjacent platforms. For instance, GE HealthCare agreed to acquire Intelerad for USD 2.3 billion in cash and framed outpatient enterprise imaging as a USD 2 billion-plus global opportunity.

This signals that imaging competition is shifting toward cloud workflow, ambulatory expansion, and recurring software revenue.

The average investment value reaches USD 49.6 million per funding round and indicates healthy deal sizes across growth-stage and late-stage companies.

The imaging segment benefits from a broad capital base, with more than 36 200 investors actively participating. To date, the imaging industry has recorded over 51 900 funding rounds and reflects consistent deal activity across imaging hardware, software, AI-driven analytics, and digital imaging infrastructure.

These investments span more than 16 400 companies and highlight wide capital distribution and sustained financial support for innovation, scale-up, and global market expansion across the imaging value chain.

The top investors collectively deployed more than USD 23.8 billion. Here is a breakdown of their contributions:

Other major deals include:

  • NVIDIA partnered with GE HealthCare to advance autonomous diagnostic imaging systems.
  • Andreessen Horowitz led a USD 40 million Series B in Q Bio that advances quantitative health imaging platforms.
  • Tencent Cloud partnered with Deshi Biotech to expand medical imaging AI capabilities.
  • EIB financed Medneo Group with EUR 30 million to expand diagnostic imaging and radiology technology platforms.
  • SoftBank invested USD 200 million in Tempus AI to advance AI-driven precision diagnostics using clinical and imaging data.

Data Notes and Limitations

This imaging tech industry outlook is built on the StartUs Insights Discovery Platform, analyzing 9M+ companies, 25K+ technologies and trends, and 190M+ patents, news articles, and market reports. It maps the imaging stack from modality hardware into DICOM interoperability, PACS/RIS modernization, cloud enterprise imaging, edge compute, and regulated clinical AI.

The report also treats adoption as an operating model shift, tracking how health systems and vendors are executing on scan-time reduction, protocol automation, radiologist capacity constraints, cybersecurity/compliance requirements, and outpatient platform expansion, alongside OEM manufacturing investments and enterprise imaging M&A.